Last reviewed · How we verify

NCT04085640: NOCH

Obturator Nerve Block in Total Hip Arthrosplasty

Completed NA Last updated 14 December 2020
What this trial tests

NA trial testing Obturator nerve block with ropivacaine 0.2%. in Primary Total Hip Arthroplasty in 60 participants. Completed in 22 September 2020.

Timeline
14 January 2020
Primary endpoint
22 September 2020
22 September 2020

Quick facts

Lead sponsorClinique Medipole Garonne
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeother
Enrollment60
Start date14 January 2020
Primary completion22 September 2020
Estimated completion22 September 2020
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Clinique Medipole Garonne

Who can join

18 and older, any sex, with Primary Total Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Interest of obturator nerve block for analgesia in total hip arthroplasty remains controversial. This regional anesthesia procedure could provide post-operative pain relief as obturator nerve is responsible for innervation of the internal part of the hip joint capsule. This randomized double-blind study aims to assess obturator nerve block for post-operative analgesia in total hip arthroplasty. Before the surgery, an ultrasound guided obturator nerve block will be performed with either 20cc of saline or ropivacaine 0.2% (a long-acting local anesthetics). After regional anesthesia, a general anesthesia will be performed for intraoperative period. This study aims to assess post-operative pain management during the first 24 hours. Ability to walk the day of the surgery will also be collected.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Obturator nerve block does not provide analgesic benefits in total hip arthroplasty under multimodal analgesic regimen: a randomized controlled trial.
    Marty P, Chassery C, Rontes O, Vuillaume C, et al · · 2021 · cited 7× · PMID 33952684 · DOI 10.1136/rapm-2021-102531

Verify or expand the search:

Other recruiting trials for Primary Total Hip Arthroplasty

Currently open trials in the same condition.

Other Clinique Medipole Garonne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04085640.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing